REBIRTH Active School 2.0 . A School Based Physical Activity Program (RAS2)

REBIRTH Active School 2.0. Impact of a School-based Physical Activity Program on the Long-term Improvement of Student Health.

Rebirth active SCHOOL 2.0 is a physical activity intervention program and about to be realised at 40 primary schools in Lower Saxony Germany.

Half of all schools will be assigned to the intervention program or to wait for one year before starting with the movement program. After one and two years, the follow up will take place. After completing baseline examinations (i.e. physical and cognitive functions, physical activity questionnaires) the intervention program will start for one year.

The intervention program is going to be designed with the goal of implementing physical activity of 60 minutes per day. For the main module of movement impulses, the pupils will perform a 5-minute exercise in every lesson, realised by the teachers.

Study Overview

• Status: Recruiting
• Conditions: Primary School Children
• Intervention / Treatment: Behavioral: Rebirth active SCHOOL 2.0 movement program

• Study Type: Interventional
• Enrollment (Anticipated): 4000
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Denise Homeyer, MSc.; Phone Number: 9114 +49 511 532; Email: homeyer.denise@mh-hannover.de
• Study Contact Backup: Name: Jeannine von der Born, Dr. med; Phone Number: 9064 +49511532; Email: vonderBorn.Jeannine@mh-hannover.de

Study Locations

• Germany
  • Lower Saxony
    • Hanover, Lower Saxony, Germany, 30625
      • Recruiting
      • Hanover Medical School
      • Contact: Denise PI Homeyer, MSc.; Phone Number: 9114 +49 511532; Email: homeyer.denise@mh-hannover.de
      • Contact: Jeannine von der Born, Dr. med.; Email: vonderBorn.Jeannine@mh-hannover.de

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 6 years to 12 years (CHILD)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• 2nd grade pupils at primary schools (District Hannover/Wolfsburg/Helmstedt/Gifhorn; Lower-Saxony, Germany),

Exclusion Criteria:

• none, if no medical contraindications against intensive physical activity/tests excist.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: PREVENTION
• Allocation: RANDOMIZED
• Interventional Model: CROSSOVER
• Masking: DOUBLE

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
EXPERIMENTAL: Interventiongroup; 60 min per day school based Physical activity program (for one year)	Behavioral: Rebirth active SCHOOL 2.0 movement program; 60 Minutes of physical activity per day integrated in every school-day.
NO_INTERVENTION: Waitinggroup; Intervention starts after one year.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in Endurance capacity via Six-Minutes Running test	Completed meters in Six-Minutes running test: German Motor Test 6-18 (Bös, 2009):	At baseline, after 1 and 2 years.
Change in Sprint velocity via 20 meter sprint	20 meter sprint test measured in seconds: German Motor Test 6-18 (Bös, 2009). Scoring the best attempt out of two.	At baseline, after 1 and 2 years.
Change in Strength tests via 40 seconds of Push ups and sit ups	Number of repetitions in 40 seconds of Push ups and sit ups: German Motor Test 6-18 (Bös, 2009)	At baseline, after 1 and 2 years.
Change in Coordination exercise: via 60 seconds Single leg stand	Ground contacts in 60 seconds Single leg stand: German Motor Test 6-18 (Bös, 2009)	At baseline, after 1 and 2 years.

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Peripheral blood pressure	Peripheral blood pressure will be measured in a seated position after a resting period of 5 minutes. We will use the oscillometric Dinamap device (Dinamap v150; Fa. GE Medical Systems, Chicago, Illinois, USA). Three measurements will be taken on the right and on the left arm. Between each measurement will be a 1 minute resting period. The Median of the left and the right arm is used for further calculations. If the Median is above the 90th percentile three measurements will be taken again by the investigator using the auscultatory method.	At baseline, after 1 and 2 years.
Central blood pressure	Central blood pressure will be measured in a spinal position using an oscillometric device, the Mobil-O-Graph (I.E.M. GmbH). The cuff size must be chosen accordingly to the arm size. After a resting period of 5 minutes 3 measurements will be taken on the right arm. Between each measurement will be 30 seconds. The mean of the 3 measurements will be used for further calculations.	At baseline, after 1 and 2 years.
Arterial pulse wave	Arterial pulse wave will be measured in a spinal position using the Vicorder. The patient should rest for 5 minutes before the start of the measurement. The thigh cuff will be placed around the patient's upper right thigh as high as possible. The cuff around the neck has to be placed over the right carotid artery. The investigator has to measure from the suprasternal notch vertically to the umbilicus and from the umbilicus diagonally to the mid of the thigh cuff. The length will be added up and the measurement from the suprasternal notch to the cuff around the neck will be subtracted. The length will be used for calculating the arterial pulse wave velocity. Three measurements will be taken with each having 10 consecutive waveforms with similar shape and size. The mean of the 3 measurements will be used for further calculations.	At baseline, after 1 and 2 years.
Quality of life via KidKindl	The quality of life will be assessed applying the KidKindl questionnaire (6 questions, Likert-Skale, 24 Items, Scale 0-100) in a 1 to 1 interview. Higher scores mean a better outcome.	At baseline, after 1 and 2 years.
Physical activity questionnaire	The physical activity will be assessed applying the physical activity questionnaire according to the KIGGS Study (MoMo Modul) in a 1 to 1 interview.	At baseline, after 1 and 2 years.
BMI (kg/m^2)	weight and height will be combined to report BMI in kg/m^2	At baseline, after 1 and 2 years.
Body Fat Mass (kg), (%)	Body Fat Mass will be measured in kilogram and percent via Body Impedance Measurement using the InBody 230.	At baseline, after 1 and 2 years.
Skeletal Muscle Mass (kg)	Skeletal Muscle Mass will be measured in kilogram via Body Impedance Measurement using the InBody 230.	At baseline, after 1 and 2 years.
Fat Free Mass (kg)	Fat Free Mass will be measured in kilogram via Body Impedance Measurement using the InBody 230.	At baseline, after 1 and 2 years.
Body height (cm)	Measured in cm	At baseline, after 1 and 2 years.
Waist - Hip circumferences (cm)	Measured in cm	At baseline, after 1 and 2 years.
Concentration ability	The concentration ability will be assessed via the CCTT (children colour trail test) using the time required to perform the test and mistakes made in the test. Percentiles can be used for the comparison with peers.	At baseline, after 1 and 2 years.
Pediatric Quality of Life	Quality of Life will be assessed via PedsQL (Quality of Life via PedsQL), 6 Questions in a 1 to 1 interview. Higher scores refect a higher quality of life.	At baseline, after 1 and 2 years.
Cognitive function	Cognitive function (Happiness/Trust/Learning) will be assessed via questionnaire in a 1 to 1 interview (Scale 0-100, a higher score means a better outcome)	At baseline, after 1 and 2 years.
Dental health Status	Dental health status will be assessed via questionnaire (6 Questions) in a 1 to 1 interview.	At baseline, after 1 and 2 years.
Program adherence	Program adherence will be assessed via Protocols by documenting the number of physical activity impulses at each participating school (minutes per day).	Whole intervention period (24 month)
Phosphat (mmol/l)	Phosphat in mmol/l will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
CysC; Cystatin C (mg/l)	CysC in mg/l, will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
Urea (mg/dl)	Urea in mg/dl will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
Kreatinin (mg/dl)	Kreatinin in mg/dl will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
Uric acid (mg/dl)	Uric acid in mg/dl will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
GPT; Glutamate pyruvate transaminase (U/l)	GPT in U/l, will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
Bilirubin (mg/dl)	Bilirubin in mg/dl, will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
Triglyceride (mg/dl)	Triglyceride in mg/dl, will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
Albumin (g/l)	Albumin in g/l, will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
CRPhs; High-sensitivity C-reactive protein (mg/l)	CRPhs in mg/l, will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
HbA1c (%)	HbA1c in % will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
Cortisol (µg/l),	Cortisol in µg/l, will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
Insulin (U/l )	Insulin in U/l, will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
Leukozyten (Tsd/µl)	Leukozyten in Tsd/µl, will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
Erythrozyten (Mio/µl)	Erythrozyten in Mio/µl, will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
Hb; Hemoglobin (g/dl),	Hb in g/dl, will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
Hkt;hematocrit (%)	Hkt in %, will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
MCHC ean corpuscular hemoglobin concentration (g/dl)	MCHC in g/dl, will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
Thrombozyten (Tsd/µl)	Thrombozyten in Tsd/µl, will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
Natrium (mmol/l)	Natrium in mmol/l, will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
Kalium (mmol/l)	Kalium in mmol/l, will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
Calcium (mmol/l)	Calcium in mmol/l, will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
Cholesterin (mg/dl)	Cholesterin in mg/dl, will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
HDL; High Density Lipoprotein (mg/dl)	HDL in mg/dl, will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
LDL; Low Density Lipoprotein (mg/dl)	LDL in mg/dl, will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
MCV; mean corpuscular volume (fl)	MCV in fl, will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
MCH; mean corpuscular hemoglobin (pg)	MCH in pg, will be measured via Blood Analysis. Blood will be taken in the morning with a fasting blood test.	At baseline, after 1 and 2 years.
Urine Analysis	Urine will be taken from the midstream urine. The children will take the sample with the help of the parents at home. The lab will measure the following urin parameters: Protein, Albumin (mg/dl), Kreatinin (g/l), Osmolarität (mOsm/kg)	At baseline, after 1 and 2 years.
Salvia Analysis	salvia	At baseline, after 1 and 2 years.
Steps per day	Steps per day will be assessed via Garmin Vivofit 4 devices.	At baseline, after 1 and 2 years.
Hours of sleep	Hours of sleep will be assessed via Garmin Vivofit 4 devices.	At baseline, after 1 and 2 years.
Metabolic Equivalent	Metabolic Equivalent (MET) (1 kcal/kg/hour) will be assessed applying Garmin Vivofit 4 devices.	At baseline, after 1 and 2 years.

Collaborators and Investigators

• Sponsor: Hannover Medical School
• Investigators: Principal Investigator: Uwe Tegtbur, Prof. Dr. med., Hannover Medical School, Hannover Lower Saxony, Germany, 30625; Principal Investigator: Anette Melk, Prof. Dr. med., Hannover Medical School, Hannover Lower Saxony, Germany, 30625

Study record dates

Study Major Dates

• Study Start (ACTUAL): June 28, 2021
• Primary Completion (ANTICIPATED): July 30, 2022
• Study Completion (ANTICIPATED): December 30, 2024

Study Registration Dates

• First Submitted: April 8, 2021
• First Submitted That Met QC Criteria: June 23, 2021
• First Posted (ACTUAL): June 28, 2021

Study Record Updates

• Last Update Posted (ACTUAL): May 20, 2022
• Last Update Submitted That Met QC Criteria: May 16, 2022
• Last Verified: May 1, 2022

More Information

Terms related to this study

• Other Study ID Numbers: 7290

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No